Scientists from Nanyang Technological University, Singapore (NTU Singapore) and Chiba University in Japan have shown how...
Precision medicine is becoming more prevalent, with pharmaceutical companies and healthcare regimen to develop highly ta...
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, ...
A randomised, placebo-controlled clinical trial led by a collaboration between Duke-NUS Medical School, National Heart C...
OBiO Technology, a world leading contract development and manufacturing organisation (CDMO) for cell and gene thera...
Longstanding alliance between Evotec and CHDI to enable the development of therapeutics for Huntington’s disease...
A research team at Osaka University, Japan will start an investigator-initiated clinical trial for refractory prostate c...
Researchers from Duke-NUS Medical School in Singapore have found that a new class of light-sensitive proteins are capabl...
A team of researchers led by Associate Professor Alfredo Franco-Obregón from the NUS Institute for Health Innovat...
Tacy Song, Head of Professional Services, Myopia, APAC at CooperVision (Left) Dr Foo Li Lian, Consultant Ophthalmo...
To mark World Clinical Trials Day on May 20, Victorian Deputy Premier and Minister for Medical Research, Ben Carro...
As Asia establishes itself as the global hub for clinical trials, Singapore is bolstering its position as the preferred ...
The Asia Pacific, Middle East and Africa (APMA) region represents almost half of the world's population but healthcare a...
Johnson & Johnson’s first-in-class, bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell-redirectin...
(Left to Right) A/Prof Too Heng-Phon (Chairman, Mirxes), Dr Zhou Lihan (Co-Founder and Chief Executive Officer, Mi...
Glioblastoma is an often fatal form of brain cancer, with only five per cent of patients surviving beyond five years. Th...
A range of hyper accurate cancer drugs is in production at a newly opened research and manufacturing hub at The Universi...
Ribobay Pharma, a leading Chinese biopharmaceutical contract research, development, and manufacturing organization (CRDM...
Francesca Ceddia, Chief Medical Affairs Officer, Moderna (Left) Dr Leong Hoe Nam, Infectious Disease Specialist, Moun...
A team of scientists from A*STAR’s Genome Institute of Singapore (GIS) and Bioinformatics Institute (BII) has deve...
Guangzhou-Israel Biotechnology Fund (GIBF) has invested $10 million in Nectin Therapeutics. Israel-b...
Rabies is a neglected zoonotic disease caused by RNA virus from Rhabdoviridae family, potentially fatal if not treated. ...
In a groundbreaking study published in Cell Research, researchers from the Yong Loo Lin School of Medicine at the Nation...
Research led by the University of Sydney and Sydney Local Health District has developed a new type of oral insulin bas...
Ora, Inc., a US-based ophthalmology contract research organisation (CRO), has announced a strategic, exclusive partnersh...
